MAZE (Maze Therapeutics) FCF Margin %: -196.03% (As of Mar. 2026)


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $27.02
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics FCF Margin %?

Maze Therapeutics MAZE +1.31% 14 FCF Margin % is -196.03% as of Mar. 2026. GuruFocus rates MAZE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Maze Therapeutics ranks worse than 74.38% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Maze Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-39.21 Mil. Maze Therapeutics's Revenue for the three months ended in Mar. 2026 was $20.00 Mil. Therefore, Maze Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was -196.03%.

As of today, Maze Therapeutics's current FCF Yield % is -8.17%.

The historical rank and industry rank for Maze Therapeutics's FCF Margin % or its related term are showing as below:

MAZE' s FCF Margin % Range Over the Past 10 Years
Min: -610.63   Med: 44.66   Max: 44.66
Current: -610.63

During the past 4 years, the highest FCF Margin % of Maze Therapeutics was 44.66%. The lowest was -610.63%. And the median was 44.66%.

MAZE's FCF Margin % is ranked worse than
74.38% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs MAZE: -610.63

Maze Therapeutics FCF Margin % Related Terms

Maze Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Maze Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maze Therapeutics FCF Margin % Chart

Maze Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 44.66 0.00

Maze Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -196.03

MAZE vs FTRE, ARDX, MBX: FCF Margin % Comparison

For the Biotechnology subindustry, Maze Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maze Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maze Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Maze Therapeutics's FCF Margin % falls into.


MAZE
14GF Score
Maze Therapeutics Inc MAZE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Maze Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-112.734/0
= %

Maze Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-39.206/20
=-196.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -196.03% mean?
Maze Therapeutics (MAZE) has a FCF Margin % of -196.03% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maze Therapeutics and its competitors. According to the industry distribution chart, Maze Therapeutics ranks #714 out of 960 companies in the Biotechnology industry, placing it in the top 74.4%.
Is Maze Therapeutics' FCF Margin % too high?
Maze Therapeutics' current FCF Margin % is -196.03%. Based on the distribution chart, Maze Therapeutics ranks #714 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Maze Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' FCF Margin % compare to FTRE and ARDX?
According to the Biotechnology industry distribution chart, Maze Therapeutics ranks #714 out of 960 companies for FCF Margin %. This places Maze Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current FCF Margin % is -196.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current FCF Margin % of -196.03%. The current FCF Margin % is -196.03%. Maze Therapeutics' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current FCF Margin % is -196.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.02
Price